Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients - Wikidata - wikimedia - TriplyDB

Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients

Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients

http://www.wikidata.org/entity/Q36763988

about

Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations Relevance of tumor-infiltrating lymphocytes in breast cancer Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer Exercise training and immune crosstalk in breast cancer microenvironment: exploring the paradigms of exercise-induced immune modulation and exercise-induced myokines Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer.Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer.Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis.Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer.Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis.Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients Expression of T-Lymphocyte Markers in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.Endoplasmic reticulum stress induces secretion of high-mobility group proteins and is associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapy Adoptive immunotherapy of metastatic breast cancer: present and future.Role of inflammatory infiltrates in triple negative breast cancer.Predictive and prognostic significance of CD8+ tumor-infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities.A review of the importance of immune responses in luminal B breast cancer.Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.Immunological and histopathological changes in sheep affected with cutaneous squamous cell carcinoma and treated immunotherapeutically.Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer.Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tu Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer.CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.Expression of NK Cell Surface Receptors in Breast Cancer Tissue as Predictors of Resistance to Antineoplastic Treatment.Early Evaluation of Relative Changes in Tumor Stiffness by Shear Wave Elastography Predicts the Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.

P2860

Q26745444-631DB0EB-4E71-4843-BBDD-340A7D68BCC8 Q26781038-C291BB26-0A37-4BC5-8EEC-6CF455D55D7C Q26795598-D0A7C916-5430-4953-BC1A-52F491547B57 Q26798074-A16FD949-59BC-4D01-84A6-38EAC3216151 Q26865918-DC20268E-873D-43E3-B60B-112D70E2C173 Q33584033-9686FBC1-D4A0-4771-8979-19D1BD5BF507 Q34454922-45BB1046-BA39-481B-856C-B3A232F7D0A0 Q34616067-3C865CEF-5B3C-4FC7-91C6-0ADBAF7EA8E3 Q34690824-C041B913-A51F-4B57-B1AE-897C11BF589B Q34789746-0C1D0F0E-7AD4-4446-A759-C26B96ADBC74 Q35009369-C440DA97-A2D0-4765-9144-12B7FD691D47 Q35218520-602237CB-8B1C-45C5-B79D-1B22FE48906F Q35992815-50E0EF3E-5F0E-4C2D-A6FB-091D2ED15F5A Q36023202-2714CCB1-519E-4C6B-B42F-DB89B7EBC8F7 Q36772903-4D3C6DED-2D88-46FE-99B2-2140CEB1C6F8 Q37323046-B18FAA86-0D29-4372-8B64-1660A1404621 Q37335249-A8C9EC6E-62B5-423E-852A-850350C21187 Q37536862-907A4B9A-24DD-4A84-AF69-92B462567FF7 Q37544396-969A1F61-E174-49F9-B35F-A9CD2DBB15D6 Q37547952-066060A6-5D12-4E2E-A5F1-F4FCC71F127C Q37644969-97652D75-8541-417C-83A7-70881818452B Q37706331-232DE858-54FB-4C16-9172-6DEE76DF10F9 Q38171325-A06989FA-51B2-4AE8-9D5D-631A184B40EC Q38370266-AE03E157-7BC1-4AE9-BFC2-FA5CC6FD8986 Q38686046-EE44104F-4B14-4F7F-9CB3-3FE0760F0BF6 Q38775011-7EAF30F6-9AA9-40EA-A6CE-8F3AE5228F41 Q38823649-1A8849E8-57F8-4DFE-87CE-7F50821BC1FE Q39172481-A5DA2275-689C-41D3-A8D3-DF0CFCAAFFF9 Q39239484-529919E9-5BF6-42D5-B81A-3ACCB36A226A Q41576606-57925597-6066-460D-9F93-FD706D1A2DBF Q43118082-367704FD-8D71-4F8D-ADF8-A6CEA53D772C Q47863345-3BF74867-09EE-406F-88CF-E8DF82F632D3 Q48121626-648039F3-02DB-48E1-AD9C-10FDEA55A154 Q48182026-79643E4B-935A-49B6-A4F7-30186EBAC59A Q48219547-26C2824C-CE66-4072-B639-B9122ED65C34 Q48270031-620327FF-A098-4C9B-83A1-33700612776A Q48850918-65882197-CF46-43F5-8B90-B2964ADEBB63 Q52725437-CAEED9FA-A88A-4859-AED3-560058A2AA16 Q53084133-7137C232-12BC-4516-9700-9B447143D01A Q53122691-27BBE07B-3349-49B8-8929-FF5E8686E8BA

P2860

Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients

http://www.wikidata.org/entity/Q36763988

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Tumor-associated lymphocytes p ...... rapy in breast cancer patients

@ast

Tumor-associated lymphocytes p ...... rapy in breast cancer patients

@en

type

label

Tumor-associated lymphocytes p ...... rapy in breast cancer patients

@ast

Tumor-associated lymphocytes p ...... rapy in breast cancer patients

@en

prefLabel

Tumor-associated lymphocytes p ...... rapy in breast cancer patients

@ast

Tumor-associated lymphocytes p ...... rapy in breast cancer patients

@en

P1433

Q36763988-EBCDDF68-6757-49FB-A9CA-B1B64A27D55D

P1476

Q36763988-0B41B8CE-1DAB-4CDC-A0AB-3BB9EFBE1E2D

P2093

Q36763988-3563DF6B-CD38-47FA-BB54-F8752AE57902

Q36763988-659EBA19-72DE-4383-BE0B-1652A7117EA3

Q36763988-9C97443B-DBA0-4A0F-934C-360CC1EF40B6

Q36763988-B589B4FB-7234-4F7D-B497-B124E9715F54

Q36763988-D1B5311A-65B2-4710-9AE6-C45511F251A4

P2860

Q36763988-029390F9-3BCD-4693-A2F8-788D4ADFAA35

Q36763988-06267B1E-4323-4DEF-86BC-96E48E549D0E

Q36763988-15F35A38-1D42-4CCD-85AC-5838495CD2E0

Q36763988-256D7FEE-E7E8-4EBC-A99C-BBF4B347A5CA

Q36763988-28F1C7C4-DD03-49E4-9957-B2F156FA7982

Q36763988-33129E9C-A967-4075-BD8B-0086844318DB

Q36763988-49FFB5E0-4DBB-4858-A59D-D15B142E8EFD

Q36763988-4AE239B9-7745-4B9F-AC03-165F6B110117

Q36763988-55811EFB-5271-46F0-B142-16588C8E8C88

Q36763988-5CF19A89-221E-469E-AF90-48EEE2C9F290

P304

Q36763988-462E30C8-FE30-4F93-976D-4D01F6535897

P31

Q36763988-AE5725BF-85DF-4EC8-B29F-E5EF1C510923

P356

Q36763988-0A733CEE-5C25-41C8-87F3-C31EFE4658C6

P433

Q36763988-44B18AF6-2E88-4B8C-865E-EF432F1DB50E

P478

Q36763988-68953B34-3453-417E-898B-D078936EA6CB

P577

Q36763988-AB131C6E-654C-4BE1-B19E-1E1C8BB20B36

P5875

Q36763988-6E8436CB-F97E-468B-B2A8-437EBC0673A9

P698

Q36763988-7FE7A562-5DC5-4E4C-B945-424E2055A121

P921

Q36763988-8ED22866-8F62-4E05-B6A1-033636C7784E

P932

Q36763988-57357BCE-C485-4435-B5F1-8E42C8F50BE1

P356

JBC.2013.16.1.32

P1433

Journal of breast cancer

P1476

Tumor-associated lymphocytes p ...... rapy in breast cancer patients

@en

P2093

Gyungyub Gong

http://www.w3.org/2001/XMLSchema#string

Hee Jin Lee

http://www.w3.org/2001/XMLSchema#string

Jin-Hee Ahn

http://www.w3.org/2001/XMLSchema#string

Jin-Young Seo

http://www.w3.org/2001/XMLSchema#string

Sei-Hyun Ahn

http://www.w3.org/2001/XMLSchema#string

P2860

Dendritic cells and the control of immunity

Mechanisms of foxp3+ T regulatory cell-mediated suppression

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.

Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.

Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.

FOXP3: of mice and men.

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer.

The anticancer immune response: indispensable for therapeutic success?

P304

32-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4048/JBC.2013.16.1.32

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236207451

http://www.w3.org/2001/XMLSchema#string

P698

23593079

http://www.w3.org/2001/XMLSchema#string

P921

P932

3625767

http://www.w3.org/2001/XMLSchema#string